News

Vertiv Holdings (NYSE:VRT) on Monday was rated Outperform in new research coverage by analysts at investment firm William ...
Jed Dorsheimer, William Blair analyst, joins 'The Exchange' to discuss Tesla's chip deal with Samsung and what it means for ...
Palo Alto Networks, Inc. (NASDAQ:PANW) is one of the best long term low volatility stocks to buy now. On July 16, William ...
In addition, The Allstate Corporation (NYSE:ALL) is taking advantage of a far better auto loss environment and employing ...
Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) is one of the best oversold NASDAQ stocks to buy now. On July 14, William Blair ...
MongoDB Inc. (NASDAQ:MDB) is one of the 11 best debt-free stocks to invest in right now. In early June, William Blair analyst ...
William Blair Names John Ivey, B.T. Remmert Co-Heads of Technology Investment Banking February 10, 2025 09:00 AM Eastern Standard Time ...
BYQLOVI is the first new ophthalmic steroid in its class in over 15 years, with a US launch expected in Q4 2025. William Blair projects peak sales of $355 million for Vevye by 2030 and $300 ...
Nayax executives will present at the William Blair Growth Conference on June 4, 2025, and hold one-on-one meetings. Nayax Ltd., a global payments and commerce enablement platform, announced that ...
William Blair, the premier global boutique with expertise in investment banking, investment management, and private wealth management, has named managing directors John Ivey and B.T. Remmert as ...